Program Goals
The program is designed to meet the educational needs of healthcare and laboratory professionals who are involved in the research, diagnosis and treatment of breast cancer.
Target Audience
The program is designed to meet the needs of physicians and other healthcare professionals interested in the management of breast cancer patients.
Educational Objectives
After completing this activity, the participant should be able to:
- Discuss the clinical trials of trastuzumab (Herceptin) in the adjuvant setting including the NSABP B-31, NCCTG N9831, HERA clinical trial, and BCIRG006 clinical trial.
- Summarize the inclusion criteria for entry to these clinical trials.
- Compare HER-2 immunohistochemistry assay results with HER-2 fluorescence in situ hybridization assay results from women eligible for entry to the BCIRG006 clinical trial.
Accreditation Statement
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Medical Education Collaborative (MEC) and Dane Garvin Ltd. Medical Education Collaborative is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation - Physician, CME
Medical Education Collaborative designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Credit Designation – Lab Professional, P.A.C.E.®
This program is approved for 1.0 contact hour of continuing education in the clinical laboratory sciences through the ASCLS P.A.C.E.® Program.Commercial Support Statement
This program is funded by an educational grant from Abbott Molecular.Faculty
Michael Fredrick Press, MD, PhD
Professor, Department of Pathology
Norris Comprehensive Cancer Center
Keck School of Medicine
The University of Southern California
Los Angles, California
Disclosure of Conflicts of Interests
Medical Education Collaborative requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Medical Education Collaborative for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.
Faculty Disclosures
| Name | Type | Commercial Supporter |
|---|---|---|
| Michael Fredrick Press, MD, PhD |
1) Speaker's Bureau | 1) Genentech, Inc. |
How to Obtain Credit
Viewers are expected to visit all presentations before attempting to take the test and activity evaluation. Successful completion will lead to the issuance of a certificate for 1.0 AMA PRA Category 1 Credit™. To receive credit, the course must be completed before August 2007.
If you attended the live presentation on June 27, 2006, and have already received CME credit for this program, you are not eligible for additional credit.
Participation in this activity should be completed in approximately 1.0 hours. Please follow these steps in order to receive CME credit for viewing the webcast:
- Read all of the CME accreditation information above.
- View the complete webcast program.
- Click on the link to apply for CME credits.
- Complete the online registration (registration is free).
- Complete the online test and/or evaluation. Participants must receive a test score of at least 70% and answer all evaluation questions to receive a certificate.
- After successfully completing the online test and evaluation, your application will be processed by the CME provider and your certificate will be sent to you. Please allow 3-4 weeks for this process.
Should you have any CME questions regarding this activity, please contact:
Medical Education Collaborative
651 Corporate Circle, Suite 104
Golden, CO 80401
866.420.3252 (toll free)
303.420.3259 (fax)
http://www.meccme.org/
How to Obtain P.A.C.E.® Credit
Viewers are expected to complete the presentation before attempting to submit contact information and the session evaluation. Successful completion will lead to the issuance of a certificate for 1.0 contact hour of P.A.C.E.® approved continuing education. To receive credit, the course must be completed before August 2007. No post-test is required through December 31, 2006; after that date a quiz must be completed to earn credit.
If you attended the live presentation on June 27, 2006, and have already received P.A.C.E.® credit for this program, you are not eligible for additional credit.
Participation in this activity should be completed in approximately 1.0 hours. Please follow these steps in order to receive P.A.C.E.® credit for viewing the webcast:
- Read all of the information above.
- View the complete webcast program.
- Click on the link to apply for P.A.C.E.® credit.
- Complete the online registration (registration is free).
- Complete the online test and/or evaluation. Participants must receive a test score of at least 70% (if taken after December 27, 2006) and answer all evaluation questions to receive a certificate.
- After successfully completing the online test and/or evaluation, your application will be processed by the P.A.C.E.® provider and your certificate will be sent to you. Please allow 3-4 weeks for this process.
Should you have any P.A.C.E.® questions regarding this activity, please contact:
ASCLS P.A.C.E.®
6701 Democracy Blvd., Suite 300
Bethesda, MD 20817-1574
Ph: 301-657-2768
Fx: 301-657-2909
http://www.ascls.org/
For technical difficulties, please consult our Technical Instructions.
Release date: August 2006
Expiration date: August 2007
“HER-2 as a Target for the Adjuvant Treatment of Breast Cancer”
You may go to - www.mshow.com and enter 298675 in the "Join a Show" login box
if you have completed viewing the webcast presentation, click here to take the post-test.
